The gastroparesis market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027; it is expected to grow at a CAGR of 4.3%during 2020-2027.
The growth of the market is mainly attributed to the increasing prevalence of diabetes and growing geriatric population. However, side effects of gastroparesis drugs obstruct the growth of the market.
Diabetes mellitus is a life-threatening chronic disease mainly caused by the body's inability to produce insulin or effectively utilize it. Diabetes is one of the global health emergencies of the 21st century. According to a report published by International Diabetes Federation (IDF) in 2019, 1 in 11 people in the world are suffering from diabetes. The total global count of people suffering from diabetes was around 463 million in 2019. Moreover, according to the same report, the prevalence of disease is expected grow by 35% by 2045. The data also suggests that almost 84 million people in Southeast Asia are diabetic; among these, 149,300 are children, and they require a daily dosage of insulin shots. In addition, the National Institutes of Health (NIH) also reported that the incidence of type 1 diabetes is increasing rapidly, and the disease is affecting a significant number of children and teenagers.
Diabetes is one of the prominent known causes of gastroparesis. The condition is characterized by damaged nerves, especially involving vagus nerves and stomach wall cells. The damage to vagus nerves affects muscle motility of stomach and small intestine. According to a study published by Johns Hopkins University, ~30-50% of the diabetic population suffers from delayed gastric emptying. The escalating incidence of diabetes mellitus due to obesity, sedentary lifestyle, and unhealthy eating habits is propelling the prevalence of gastroparesis.
The COVID-19 pandemic has disrupted supply chain of over-the-counter (OTC) and prescription drugs, and this is likely to limit the market growth in the next few quarters. Moreover, prime focus of health care providers and medical industries on COVID-19 has led to the lowered focus on the diagnosis and treatment for gastroparesis, which is limiting the market growth to a certain extent.
On the basis of type, the gastroparesis market is segmented into idiopathic, diabetic, post-surgical, and others. The idiopathic type held the largest share of the market in 2019; however, the market for the diabetic segment is estimated to grow at the highest CAGR during the forecast period.
The gastroparesis market, by drug class type, is segmented into prokinetic agents, antiemetic agents, and botulinum toxin injections. The prokinetic agents segment held the largest share of the market in 2019 and is estimated to register the highest CAGR during 2020-2027.
On the basis of distribution channel, the gastroparesis market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019 and is expected to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), National Health Service (NHS), and Centers for Disease Control and Prevention (CDC) are among the major primary and secondary sources referred to while preparing this report.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
 1.3.1 Global Gastroparesis Market - By Type
 1.3.2 Global Gastroparesis Market - By Drug Class Type
 1.3.3 Global Gastroparesis Market - By Distribution Channel
 1.3.4 Global Gastroparesis Market - By Geography
2. Gastroparesis Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Gastroparesis Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
 4.2.1 North America- PEST Analysis
 4.2.2 Europe- PEST Analysis
 4.2.3 Asia Pacific- PEST Analysis
 4.2.4 Middle East & Africa- PEST Analysis
 4.2.5 South and Central America- PEST Analysis
4.3 Expert Opinion
5. Gastroparesis Market - Key Market Dynamics
5.1 Market Drivers
 5.1.1 Rising Diabetes Mellitus Prevalence
 5.1.2 Increasing Geriatric Population
5.2 Market Restraints
 5.2.1 Side Effects of Gastroparesis Drugs
5.3 Market Opportunities
 5.3.1 Surging Investments and Financial Assistance for Research
5.4 Future Trends
 5.4.1 Emphasis on Gastric Electrical Stimulation Therapy Research
5.5 Impact Analysis
6. Gastroparesis Market - Global Analysis
6.1 Global Gastroparesis Market Revenue Forecast And Analysis
6.2 Global Gastroparesis Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Gastroparesis Market Analysis - By Type
7.1 Overview
7.2 Gastroparesis Market Revenue Share, by Type (2019 and 2027)
7.3 Idiopathic
 7.3.1 Overview
 7.3.2 Idiopathic: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Diabetic
 7.4.1 Overview
 7.4.2 Diabetic: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Post-Surgical
 7.5.1 Overview
 7.5.2 Post-Surgical: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Others
 7.6.1 Overview
 7.6.2 Others: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
8. Gastroparesis Market Analysis - By Drug Class Type
8.1 Overview
8.2 Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)
8.3 Prokinetic Agents
 8.3.1 Overview
 8.3.2 Prokinetic Agents: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Botulinum Toxin Injection
 8.4.1 Overview
 8.4.2 Botulinum Toxin Injection: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Antiemetic Agents
 8.5.1 Overview
 8.5.2 Antiemetic Agents: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
9. Gastroparesis Market Analysis - By Distribution Channel
9.1 Overview
9.2 Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Retail Pharmacies
 9.3.1 Overview
 9.3.2 Retail Pharmacies: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Hospital Pharmacies
 9.4.1 Overview
 9.4.2 Hospital Pharmacies: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Others
 9.5.1 Overview
 9.5.2 Others: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
10. Gastroparesis Market - Geographic Analysis
10.1 North America: Gastroparesis Market
 10.1.1 Overview
 10.1.2 North America: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.1.3 North America Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.1.4 North America Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.1.5 North America Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.1.6 North America: Gastroparesis Market, by Country, 2019 & 2027 (%)
 10.1.7 US: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.1.7.1 US: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.1.7.2 US Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.1.7.3 US Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.1.7.4 US Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.1.8 Canada: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.1.8.1 Canada: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.1.8.2 Canada Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.1.8.3 Canada Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.1.8.4 Canada Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.1.9 Mexico: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.1.9.1 Mexico: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.1.9.2 Mexico Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.1.9.3 Mexico Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.1.9.4 Mexico Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Gastroparesis Market
 10.2.1 Overview
 10.2.2 Europe: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.3 Europe Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.2.4 Europe Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.2.5 Europe Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.2.6 Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)
 10.2.7 Germany: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.7.1 Germany: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.7.2 Germany Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.2.7.3 Germany Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.2.7.4 Germany Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.2.8 UK: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.8.1 UK: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.8.2 UK Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.2.8.3 UK Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.2.8.4 UK Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.2.9 France: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.9.1 France: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.9.2 France Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.2.9.3 France Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.2.9.4 France Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.2.10 Spain: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.10.1 Spain: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.10.2 Spain Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.2.10.3 Spain Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.2.10.4 Spain Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.2.11 Italy: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.11.1 Italy: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.11.2 Italy Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.2.11.3 Italy Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.2.11.4 Italy Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.2.12 Rest of Europe: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.12.1 Rest of Europe: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.2.12.2 Rest of Europe Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.2.12.3 Rest of Europe Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.2.12.4 Rest of Europe Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Gastroparesis Market
 10.3.1 Overview
 10.3.2 Asia Pacific: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.3 Asia Pacific Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.3.4 Asia Pacific Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.3.4.1 Asia Pacific Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
 10.3.5 Asia Pacific: Gastroparesis Market, by Country, 2019 & 2027 (%)
 10.3.6 China: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.6.1 China: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.6.2 China Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.3.6.3 China Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.3.6.3.1 China Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
 10.3.7 Japan: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.7.1 Japan: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.7.2 Japan Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.3.7.3 Japan Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.3.7.3.1 Japan Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
 10.3.8 India: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.8.1 India: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.8.2 India Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.3.8.3 India Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.3.8.4 India Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
 10.3.9 South Korea: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.9.1 South Korea: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.9.2 South Korea Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.3.9.3 South Korea Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.3.9.4 South Korea Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
 10.3.10 Australia: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.10.1 Australia: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.10.2 Australia Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.3.10.3 Australia Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.3.10.4 Australia Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
 10.3.11 Rest of Asia Pacific: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.11.1 Rest of Asia Pacific: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.3.11.2 Rest of Asia Pacific Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.3.11.3 Rest of Asia Pacific Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.3.11.4 Rest of Asia Pacific Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Gastroparesis Market
 10.4.1 Overview
 10.4.2 Middle East & Africa: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
 10.4.3 Middle East & Africa Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.4.4 Middle East & Africa Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.4.5 Middle East & Africa Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.4.6 Middle East & Africa: Gastroparesis Market, by Country, 2019 & 2027 (%)
 10.4.7 Saudi Arabia: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.4.7.1 Saudi Arabia: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.4.7.2 Saudi Arabia Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.4.7.3 Saudi Arabia Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.4.7.4 Saudi Arabia Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.4.8 UAE: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.4.8.1 UAE: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.4.8.2 UAE Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.4.8.3 UAE Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.4.8.4 UAE Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.4.9 South Africa: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.4.9.1 South Africa: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.4.9.2 South Africa Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.4.9.3 South Africa Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.4.9.4 South Africa Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.4.9.5 Rest of Middle East and Africa: Gastroparesis Market - Revenue and Forecasts to 2027 (USD Million)
 10.4.9.5.1 Rest of Middle East and Africa: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)
 10.4.9.6 Rest of Middle East and Africa Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.4.9.7 Rest of Middle East and Africa Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.4.9.8 Rest of Middle East and Africa Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Gastroparesis Market
 10.5.1 Overview
 10.5.2 South and Central America: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.5.3 South and Central America Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.5.4 South and Central America Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.5.5 South and Central America Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.5.6 South and Central America: Gastroparesis Market, by Country, 2019 & 2027 (%)
 10.5.7 Brazil: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.5.7.1 Brazil: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.5.7.2 Brazil Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.5.7.3 Brazil Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.5.7.4 Brazil Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.5.8 Argentina: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.5.8.1 Argentina: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
 10.5.8.2 Argentina Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.5.8.3 Argentina Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.5.8.4 Argentina Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
 10.5.8.5 Rest of South and Central America: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)
 10.5.8.5.1 Rest of South and Central America: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)
 10.5.8.6 Rest of South and Central America Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
 10.5.8.7 Rest of South and Central America Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
 10.5.8.8 Rest of South and Central America Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Gastroparesis Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Gastroparesis Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Gastroparesis Market, 2018-2020
12.3 Inorganic Growth Strategies
 12.3.1 Overview
12.4 Organic Growth Strategies
 12.4.1 Overview
13. Company Profiles
13.1 Evoke Pharma
 13.1.1 Key Facts
 13.1.2 Business Description
 13.1.3 Products and Services
 13.1.4 Financial Overview
 13.1.5 SWOT Analysis
 13.1.6 Key Developments
13.2 Allergan Plc.
 13.2.1 Key Facts
 13.2.2 Business Description
 13.2.3 Products and Services
 13.2.4 Financial Overview
 13.2.5 SWOT Analysis
 13.2.6 Key Developments
13.3 NEUROGASTRX, INC.
 13.3.1 Key Facts
 13.3.2 Business Description
 13.3.3 Products and Services
 13.3.4 Financial Overview
 13.3.5 SWOT Analysis
 13.3.6 Key Developments
13.4 Bausch Health Companies Inc.( Salix Pharmaceuticals)
 13.4.1 Key Facts
 13.4.2 Business Description
 13.4.3 Products and Services
 13.4.4 Financial Overview
 13.4.5 SWOT Analysis
 13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
 13.5.1 Key Facts
 13.5.2 Business Description
 13.5.3 Products and Services
 13.5.4 Financial Overview
 13.5.5 SWOT Analysis
 13.5.6 Key Developments
13.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
 13.6.1 Key Facts
 13.6.2 Business Description
 13.6.3 Products and Services
 13.6.4 Financial Overview
 13.6.5 SWOT Analysis
 13.6.6 Key Developments
13.7 Pfizer Inc.
 13.7.1 Key Facts
 13.7.2 Business Description
 13.7.3 Products and Services
 13.7.4 Financial Overview
 13.7.5 SWOT Analysis
 13.7.6 Key Developments
13.8 ANI Pharmaceuticals, Inc.
 13.8.1 Key Facts
 13.8.2 Business Description
 13.8.3 Products and Services
 13.8.4 Financial Overview
 13.8.5 SWOT Analysis
 13.8.6 Key Developments
13.9 Ipca Laboratories Ltd
 13.9.1 Key Facts
 13.9.2 Business Description
 13.9.3 Products and Services
 13.9.4 Financial Overview
 13.9.5 SWOT Analysis
 13.9.6 Key Developments
13.10 CinRx Pharma, LLC (CinDome Pharma)
 13.10.1 Business Description
 13.10.2 Products and Services
 13.10.3 Financial Overview
 13.10.4 SWOT Analysis
 13.10.5 Key Developments
14. Appendix
14.1 About
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Gastroparesis Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 2. North America Gastroparesis Market, by Drug Class Type- Revenue and Forecast to 2027 (USD Million)
Table 3. North America Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 4. US Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 5. US Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 6. US Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 16. Germany Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 19. UK Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 20. UK Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 21. UK Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 22. France Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. France Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 24. France Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 25. Spain Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 29. Italy Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 30. Italy Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 31. Rest of Europe Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 32. Rest of Europe Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 33. Rest of Europe Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 34. Asia Pacific Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 35. Asia Pacific Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 36. Asia Pacific Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 37. China Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 38. China Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 39. China Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 40. Japan Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 41. Japan Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 42. Japan Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 43. India Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 44. India Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 45. India Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 46. South Korea Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 47. South Korea Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 48. South Korea Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 49. Australia Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 50. Australia Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 51. Australia Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 52. Rest of Asia Pacific Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of Asia Pacific Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of Asia Pacific Gastroparesis Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 55. Middle East & Africa Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 56. Middle East & Africa Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 57. Middle East & Africa Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 58. Saudi Arabia Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 59. Saudi Arabia Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 60. Saudi Arabia Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 61. UAE Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 62. UAE Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 63. UAE Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 64. South Africa Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 65. South Africa Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 66. South Africa Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 67. Rest of Middle East and Africa Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 68. Rest of Middle East and Africa Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 69. Rest of Middle East and Africa Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 70. South and Central America Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 71. South and Central America Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 72. South and Central America Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 73. Brazil Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 74. Brazil Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 75. Brazil Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 76. Argentina Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 77. Argentina Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 78. Argentina Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 79. Rest of South and Central America Gastroparesis Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 80. Rest of South and Central America Gastroparesis Market, by Drug Class Type - Revenue and Forecast to 2027 (USD Million)
Table 81. Rest of South and Central America Gastroparesis Market, by Distribution Channel- Revenue and Forecast to 2027 (USD Million)
Table 82. Recent Inorganic Growth Strategies in the Gastroparesis market
Table 83. Recent Organic Growth Strategies In the Gastroparesis market
Table 84. Glossary of Terms, Gastroparesis Market
LIST OF FIGURES
Figure 1. Gastroparesis Market Segmentation
Figure 2. Gastroparesis Market Segmentation, By Region
Figure 3. Gastroparesis Market Overview
Figure 4. Idiopathic Segment Held Largest Share of Gastroparesis Market
Figure 5. APAC to Show Remarkable Growth During Forecast Period
Figure 6. Gastroparesis Market, by Geography (US$ Million)
Figure 7. Global Gastroparesis Market - Leading Country Markets (US$ Million)
Figure 8. Global Gastroparesis Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Gastroparesis Market Impact Analysis of Drivers and Restraints
Figure 15. Global Gastroparesis Market - Revenue Forecast And Analysis - 2019- 2027
Figure 16. Global Gastroparesis Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Gastroparesis Market
Figure 18. Gastroparesis Market Revenue Share, by Type (2019 and 2027)
Figure 19. Idiopathic: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Diabetic: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Post-Surgical: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Others: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)
Figure 24. Prokinetic Agents: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Botulinum Toxin Injection: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Antiemetic Agents: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 28. Retail Pharmacies: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Hospital Pharmacies: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Others: Gastroparesis Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. North America: Gastroparesis Market, by Key Country - Revenue (2019) (USD Million)
Figure 32. North America Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 34. US: Pharmaceutical Drug Delivery market - Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Mexico: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Europe: Gastroparesis Market, by Key Country - Revenue (2019) (USD Million)
Figure 38. Europe Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 40. Germany: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. UK: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. France: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Spain: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Italy: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Rest of Europe: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 46. Asia Pacific: Gastroparesis Market, by Key Country - Revenue (2019) (USD Million)
Figure 47. Asia Pacific Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 48. China: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 49. Japan: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. South Korea: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. Australia: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Rest of Asia Pacific: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Middle East & Africa: Gastroparesis Market, by Key Country - Revenue (2019) (USD Million)
Figure 55. Middle East & Africa Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Middle East & Africa: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 57. Saudi Arabia: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. UAE: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. South Africa: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Rest of Middle East and Africa: Gastroparesis Market- Revenue And Forecasts To 2027 (USD Million)
Figure 61. South and Central America: Gastroparesis Market, by Key Country - Revenue (2019) (USD Million)
Figure 62. South and Central America Gastroparesis Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Gastroparesis Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Gastroparesis Market - Revenue and Forecast to 2027 (USD Million)
Fig
EVOKE PHARMA
Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
Johnson and Johnson Services, Inc.
Allergan Plc
NEUROGASTRX, INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pfizer Inc.
ANI Pharmaceuticals, Inc.
Ipca Laboratories Ltd.
Cinrx Pharma, LLC (Cindome Pharma)